• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Center for Connected Health, Daiichi Sankyo ink mobile app agreement

Center for Connected Health, Daiichi Sankyo ink mobile app agreement

October 23, 2014
CenterWatch Staff

The Center for Connected Health, a division of Partners HealthCare, a Boston-based healthcare delivery system founded by Harvard Medical School affiliated teaching institutions Brigham and Women's Hospital and Massachusetts General Hospital, has announced a co-development agreement with Japanese pharmaceutical Daiichi Sankyo to create a mobile app to serve as a coaching platform for patients with atrial fibrillation who have been prescribed oral anticoagulation therapy.

The goal of this mobile app will be to support patients living with atrial fibrillation by helping improve patient adherence and compliance to medication, as well as fostering feedback loops that connect the provider to the patient.

Many pharmaceutical and life sciences companies are incorporating mobile and connected health tools to support clinical trial recruitment and data collection, as well as medication adherence, patient engagement and disease management programs. At the same time, the Affordable Care Act (ACA) is changing the way providers think about and deliver care to patients. Many innovative pharmaceutical companies are responding to these changes via connected health solutions as a way to help improve patient care and clinical outcomes. 

"By leveraging ubiquitous mobile technologies, we can help enable providers to engage patients in new ways that provide disease education, motivation, reminders and other medication compliance strategies," said Joseph C. Kvedar, M.D., director, Center for Connected Health. "Our research has demonstrated that mobile health tools, including apps and text messaging programs, are effective means to engage patients in their care, supporting healthy behavior change and overall patient engagement. In today's era of accountable care, creating opportunities for successful treatment, improved outcomes and patient satisfaction is critical. By embracing connected health technologies, pharmaceutical companies can truly move 'beyond the pill.' ”

The center has created and deployed mobile technologies in a number of patient populations and care settings. The center's research team also is conducting innovative clinical studies to test the effectiveness of mobile health technologies in various clinical applications, including medication adherence, care coordination, pain and chronic disease management and prevention and wellness.

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing